spacer
home > ebr > summer 2002 > beyond borders - ernst & young's global biotechnology report 2002
PUBLICATIONS
European Biopharmaceutical Review

Beyond Borders - Ernst & Young's Global Biotechnology Report 2002

Reflecting the reality in which the global biotechnology industry now operates, Ernst & Young's Global Health Sciences Group recently launched the latest of their well-known regional biotechnology industry reports as a single global document at the recent annual international BIO Convention in Toronto in June. Beyond Borders - The Global Biotechnology Industry Report 2002, or 'global book' as those who have become familiar with this excellent publication describe it, is an extremely useful report for all interested participants in today's biotechnology marketplace. It is to be applauded for capturing not only the most up-to-date benchmark data on growth and financing trends but also the essence of the most pertinent issues for the global biopharma sector today.Assembled from knowledge researched within the different regional territories of Ernst & Young's Global Health Sciences Team, the report is divided into two sections. The first, The Global Marketplace, sets out data and trends from the global industry principally represented by the 25 countries that have fostered the growth of the sector and which are also responsible for 79 per cent of global gross domestic product.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Senior Consultant at Technomark Consulting Services
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement